U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 475

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr15:65369414
GRCh38:
Chr15:65077076
KBTBD13F87LNemaline myopathy 6Uncertain significance
(Apr 9, 2019)
criteria provided, single submitter
2.
GRCh37:
Chr15:65369329-65369330
GRCh38:
Chr15:65076991-65076992
KBTBD13R59QNemaline myopathy 6Uncertain significance
(Jul 28, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr15:65369503
GRCh38:
Chr15:65077165
KBTBD13G117ANemaline myopathy 6Uncertain significance
(Nov 28, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr15:65369319
GRCh38:
Chr15:65076981
KBTBD13G56RNemaline myopathy 6Uncertain significance
(Dec 30, 2020)
criteria provided, single submitter
5.
GRCh37:
Chr15:65370140
GRCh38:
Chr15:65077802
KBTBD13Nemaline myopathy 6Likely benign
(Jul 6, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr15:65369767
GRCh38:
Chr15:65077429
KBTBD13A205VNemaline myopathy 6Uncertain significance
(Apr 11, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr15:65370475
GRCh38:
Chr15:65078137
KBTBD13L441QNemaline myopathy 6Uncertain significance
(Jul 3, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr15:65370340
GRCh38:
Chr15:65078002
KBTBD13A396VNemaline myopathy 6, not providedUncertain significance
(Mar 29, 2023)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr15:65369293
GRCh38:
Chr15:65076955
KBTBD13E47GNemaline myopathy 6Uncertain significance
(Mar 18, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr15:65369445
GRCh38:
Chr15:65077107
KBTBD13E98*Nemaline myopathy 6Uncertain significance
(Dec 11, 2021)
criteria provided, single submitter
11.
GRCh37:
Chr15:65370201
GRCh38:
Chr15:65077863
KBTBD13R350CNemaline myopathy 6Uncertain significance
(May 12, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr15:65369295
GRCh38:
Chr15:65076957
KBTBD13V48LNemaline myopathy 6Likely benign
(Oct 25, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr15:65369733
GRCh38:
Chr15:65077395
KBTBD13P194SNemaline myopathy 6Uncertain significance
(May 15, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr15:65370452
GRCh38:
Chr15:65078114
KBTBD13Nemaline myopathy 6Likely benign
(Jul 31, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr15:65369378
GRCh38:
Chr15:65077040
KBTBD13Nemaline myopathy 6Likely benign
(May 12, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr15:65369352
GRCh38:
Chr15:65077014
KBTBD13G67SNemaline myopathy 6Uncertain significance
(Feb 23, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr15:65370417
GRCh38:
Chr15:65078079
KBTBD13Nemaline myopathy 6Likely benign
(Mar 19, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr15:65370039
GRCh38:
Chr15:65077701
KBTBD13A296TNemaline myopathy 6Uncertain significance
(Jan 17, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr15:65369327
GRCh38:
Chr15:65076989
KBTBD13F58LInborn genetic diseases, Nemaline myopathy 6Uncertain significance
(Apr 17, 2023)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr15:65369853
GRCh38:
Chr15:65077515
KBTBD13D234NNemaline myopathy 6Uncertain significance
(Feb 1, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr15:65369807
GRCh38:
Chr15:65077469
KBTBD13Nemaline myopathy 6Likely benign
(Aug 1, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr15:65369937
GRCh38:
Chr15:65077599
KBTBD13A262TNemaline myopathy 6Uncertain significance
(Apr 9, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr15:65370154
GRCh38:
Chr15:65077816
KBTBD13A334DNemaline myopathy 6Uncertain significance
(Sep 27, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr15:65370178
GRCh38:
Chr15:65077840
KBTBD13Y342CNemaline myopathy 6, Inborn genetic diseasesUncertain significance
(Apr 13, 2023)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr15:65369294
GRCh38:
Chr15:65076956
KBTBD13Nemaline myopathy 6Likely benign
(Feb 2, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr15:65370303
GRCh38:
Chr15:65077965
KBTBD13G384SNemaline myopathy 6Uncertain significance
(Aug 6, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr15:65370020
GRCh38:
Chr15:65077682
KBTBD13Nemaline myopathy 6Likely benign
(Mar 20, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr15:65369178
GRCh38:
Chr15:65076840
KBTBD13V9LNemaline myopathy 6Uncertain significance
(Apr 17, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr15:65369174
GRCh38:
Chr15:65076836
KBTBD13Nemaline myopathy 6Likely benign
(Jun 26, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr15:65369523
GRCh38:
Chr15:65077185
KBTBD13S124GNemaline myopathy 6Uncertain significance
(Nov 1, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr15:65370084
GRCh38:
Chr15:65077746
KBTBD13Nemaline myopathy 6Likely benign
(May 21, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr15:65369184
GRCh38:
Chr15:65076846
KBTBD13V11MNemaline myopathy 6Uncertain significance
(Oct 20, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr15:65369331
GRCh38:
Chr15:65076993
KBTBD13A60PNemaline myopathy 6Uncertain significance
(Jun 20, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr15:65369286
GRCh38:
Chr15:65076948
KBTBD13A45SNemaline myopathy 6Benign
(Sep 6, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr15:65369291
GRCh38:
Chr15:65076953
KBTBD13Nemaline myopathy 6Likely benign
(Feb 11, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr15:65369176
GRCh38:
Chr15:65076838
KBTBD13L8PNemaline myopathy 6Uncertain significance
(May 23, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr15:65369215
GRCh38:
Chr15:65076877
KBTBD13D21ANemaline myopathy 6Likely benign
(Aug 22, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr15:65370427
GRCh38:
Chr15:65078089
KBTBD13R425TNemaline myopathy 6Uncertain significance
(Oct 17, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr15:65370222
GRCh38:
Chr15:65077884
KBTBD13R357CNemaline myopathy 6Uncertain significance
(Jun 10, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr15:65370359
GRCh38:
Chr15:65078021
KBTBD13Nemaline myopathy 6Likely benign
(Apr 8, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr15:65369597
GRCh38:
Chr15:65077259
KBTBD13Y148*Nemaline myopathy 6Uncertain significance
(Apr 4, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr15:65370173
GRCh38:
Chr15:65077835
KBTBD13Q340HNemaline myopathy 6Uncertain significance
(Mar 26, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr15:65370373-65370374
GRCh38:
Chr15:65078035-65078036
KBTBD13R408fsNemaline myopathy 6Uncertain significance
(Sep 6, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr15:65369531-65369532
GRCh38:
Chr15:65077193-65077194
KBTBD13L127VNemaline myopathy 6Likely benign
(Mar 7, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr15:65369318
GRCh38:
Chr15:65076980
KBTBD13Nemaline myopathy 6Likely benign
(Apr 8, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr15:65369609-65369610
GRCh38:
Chr15:65077271-65077272
KBTBD13Nemaline myopathy 6Likely benign
(Jan 20, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr15:65369422
GRCh38:
Chr15:65077084
KBTBD13A90VNemaline myopathy 6Uncertain significance
(Apr 20, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr15:65369672
GRCh38:
Chr15:65077334
KBTBD13Nemaline myopathy 6Likely benign
(Oct 31, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr15:65369299
GRCh38:
Chr15:65076961
KBTBD13R49PNemaline myopathy 6Uncertain significance
(Oct 26, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr15:65369945
GRCh38:
Chr15:65077607
KBTBD13Nemaline myopathy 6Likely benign
(Jan 11, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr15:65369553
GRCh38:
Chr15:65077215
KBTBD13R134GNemaline myopathy 6Uncertain significance
(Apr 29, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr15:65369274
GRCh38:
Chr15:65076936
KBTBD13Nemaline myopathy 6Likely benign
(Aug 8, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr15:65370233
GRCh38:
Chr15:65077895
KBTBD13Nemaline myopathy 6Likely benign
(Aug 16, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr15:65370155
GRCh38:
Chr15:65077817
KBTBD13Nemaline myopathy 6Likely benign
(Aug 26, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr15:65369371
GRCh38:
Chr15:65077033
KBTBD13A73ENemaline myopathy 6Uncertain significance
(Dec 24, 2021)
criteria provided, single submitter
56.
GRCh37:
Chr15:65369378
GRCh38:
Chr15:65077040
KBTBD13E75DNemaline myopathy 6Uncertain significance
(Sep 16, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr15:65370378
GRCh38:
Chr15:65078040
KBTBD13M409LNemaline myopathy 6Benign
(Aug 23, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr15:65369627
GRCh38:
Chr15:65077289
KBTBD13Nemaline myopathy 6Likely benign
(Apr 21, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr15:65369236
GRCh38:
Chr15:65076898
KBTBD13H28RNemaline myopathy 6Uncertain significance
(May 4, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr15:65369893
GRCh38:
Chr15:65077555
KBTBD13P247RNemaline myopathy 6Uncertain significance
(May 7, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr15:65369587
GRCh38:
Chr15:65077249
KBTBD13A145DNemaline myopathy 6Uncertain significance
(Aug 23, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr15:65370362
GRCh38:
Chr15:65078024
KBTBD13Nemaline myopathy 6Uncertain significance
(Jun 24, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr15:65369328
GRCh38:
Chr15:65076990
KBTBD13R59GNemaline myopathy 6Uncertain significance
(Jun 19, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr15:65369996
GRCh38:
Chr15:65077658
KBTBD13Nemaline myopathy 6Uncertain significance
(Oct 25, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr15:65369624-65369625
GRCh38:
Chr15:65077286-65077287
KBTBD13A158fsNemaline myopathy 6Uncertain significance
(Aug 27, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr15:65369742
GRCh38:
Chr15:65077404
KBTBD13A197TNemaline myopathy 6Uncertain significance
(Jun 24, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr15:65369359
GRCh38:
Chr15:65077021
KBTBD13R69PNemaline myopathy 6Uncertain significance
(Aug 8, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr15:65369611
GRCh38:
Chr15:65077273
KBTBD13R153QInborn genetic diseases, Nemaline myopathy 6Conflicting interpretations of pathogenicity
(Jan 24, 2023)
criteria provided, conflicting interpretations
69.
GRCh37:
Chr15:65369445
GRCh38:
Chr15:65077107
KBTBD13E98QNemaline myopathy 6Uncertain significance
(May 3, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr15:65369806
GRCh38:
Chr15:65077468
KBTBD13R218HNemaline myopathy 6Uncertain significance
(Oct 9, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr15:65369256
GRCh38:
Chr15:65076918
KBTBD13L35FNemaline myopathy 6Uncertain significance
(Dec 29, 2021)
criteria provided, single submitter
72.
GRCh37:
Chr15:65369716
GRCh38:
Chr15:65077378
KBTBD13R188HNemaline myopathy 6Uncertain significance
(Jan 6, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr15:65369859
GRCh38:
Chr15:65077521
KBTBD13G236SNemaline myopathy 6Uncertain significance
(Feb 2, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr15:65370187
GRCh38:
Chr15:65077849
KBTBD13C345SNemaline myopathy 6Uncertain significance
(Apr 23, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr15:65369329
GRCh38:
Chr15:65076991
KBTBD13R59HNemaline myopathy 6Uncertain significance
(Oct 10, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr15:65369382
GRCh38:
Chr15:65077044
KBTBD13E77QNemaline myopathy 6Uncertain significance
(Dec 21, 2021)
criteria provided, single submitter
77.
GRCh37:
Chr15:65369250
GRCh38:
Chr15:65076912
KBTBD13R33GNemaline myopathy 6Uncertain significance
(Aug 27, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr15:65369344
GRCh38:
Chr15:65077006
KBTBD13V64GNemaline myopathy 6Uncertain significance
(Dec 23, 2021)
criteria provided, single submitter
79.
GRCh37:
Chr15:65369793
GRCh38:
Chr15:65077455
KBTBD13V214MNemaline myopathy 6Uncertain significance
(Oct 21, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr15:65369936
GRCh38:
Chr15:65077598
KBTBD13Nemaline myopathy 6Likely benign
(Aug 4, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr15:65369745
GRCh38:
Chr15:65077407
KBTBD13S198GNemaline myopathy 6Uncertain significance
(Nov 27, 2021)
criteria provided, single submitter
82.
GRCh37:
Chr15:65369815
GRCh38:
Chr15:65077477
KBTBD13S221NNemaline myopathy 6Benign
(Aug 9, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr15:65369680
GRCh38:
Chr15:65077342
KBTBD13T176MNemaline myopathy 6, Inborn genetic diseasesUncertain significance
(May 11, 2022)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr15:65369484
GRCh38:
Chr15:65077146
KBTBD13D111HNemaline myopathy 6Uncertain significance
(Sep 7, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr15:65370386
GRCh38:
Chr15:65078048
KBTBD13Nemaline myopathy 6Likely benign
(Mar 19, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr15:65369488
GRCh38:
Chr15:65077150
KBTBD13A112ENemaline myopathy 6, not specifiedUncertain significance
(Dec 30, 2022)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr15:65370045
GRCh38:
Chr15:65077707
KBTBD13V298LNemaline myopathy 6Uncertain significance
(Sep 30, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr15:65369921
GRCh38:
Chr15:65077583
KBTBD13F256LNemaline myopathy 6Uncertain significance
(Oct 20, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr15:65369585
GRCh38:
Chr15:65077247
KBTBD13E144DNemaline myopathy 6Uncertain significance
(Aug 23, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr15:65369218
GRCh38:
Chr15:65076880
KBTBD13R22LNemaline myopathy 6Uncertain significance
(Aug 6, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr15:65370323
GRCh38:
Chr15:65077985
KBTBD13K390Nnot provided, Nemaline myopathy 6Likely pathogenic
(Jun 1, 2023)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr15:65369998-65369999
GRCh38:
Chr15:65077660-65077661
KBTBD13C284fsNemaline myopathy 6Uncertain significance
(Oct 19, 2020)
criteria provided, single submitter
93.
GRCh37:
Chr15:65369810
GRCh38:
Chr15:65077472
KBTBD13Nemaline myopathy 6Likely benign
(Aug 12, 2021)
criteria provided, single submitter
94.
GRCh37:
Chr15:65369571
GRCh38:
Chr15:65077233
KBTBD13Nemaline myopathy 6Likely benign
(Jul 6, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr15:65369318
GRCh38:
Chr15:65076980
KBTBD13Nemaline myopathy 6Likely benign
(Jun 27, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr15:65369638
GRCh38:
Chr15:65077300
KBTBD13T162MNemaline myopathy 6Likely benign
(Sep 28, 2021)
criteria provided, single submitter
97.
GRCh37:
Chr15:65370371
GRCh38:
Chr15:65078033
KBTBD13Nemaline myopathy 6Likely benign
(Jul 3, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr15:65370394
GRCh38:
Chr15:65078056
KBTBD13Y414CNemaline myopathy 6Likely benign
(Jun 27, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr15:65370359
GRCh38:
Chr15:65078021
KBTBD13Nemaline myopathy 6Likely benign
(Sep 6, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr15:65370074
GRCh38:
Chr15:65077736
KBTBD13Nemaline myopathy 6Likely benign
(Oct 9, 2021)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination